Iterum Therapeutics PLC (ITRM) — DEFA14A Filings

All DEFA14A filings from Iterum Therapeutics PLC. Browse 5 DEFA14A reports with AI-powered summaries and risk analysis.

DEFA14A Filings (5)

  • Iterum Therapeutics Files Proxy Materials — Sep 30, 2024 Risk: low
    Iterum Therapeutics plc filed a Definitive Additional Materials proxy statement on September 30, 2024. This filing is related to the company's proxy materials a
  • Iterum Therapeutics Files Proxy Statement — Sep 24, 2024 Risk: low
    Iterum Therapeutics plc filed a DEFA14A on September 24, 2024, related to its proxy statement. The filing indicates no fee was required for this submission, sug
  • Iterum Therapeutics Files Proxy Materials — Sep 23, 2024 Risk: low
    Iterum Therapeutics plc filed a Definitive Additional Materials proxy statement on September 23, 2024. This filing is related to the company's proxy statement a
  • Iterum Therapeutics Files Proxy Materials — Sep 11, 2024 Risk: low
    Iterum Therapeutics plc filed a Definitive Additional Materials proxy statement on September 11, 2024. This filing relates to the company's solicitation of prox
  • Iterum Therapeutics Files Proxy Materials — Sep 9, 2024 Risk: low
    Iterum Therapeutics plc filed a Definitive Additional Materials proxy statement on September 9, 2024. This filing is related to the company's proxy materials an

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.